Buy Cerebrolysin

Cerebrolysin is available directly from New-U Research Compounds at https://new-u.io/peptide/cerebrolysin. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% HPLC purity, supplied as lyophilised research-grade material, and shipped direct from source worldwide (approximately 6–14 business days).

Cerebrolysin starts at $36 for a 1-vial research pack (60mg per vial) at New-U Research Compounds, with 2 pack sizes available. Orders over $300 ship free.

Yes. Every Cerebrolysin batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC area normalisation.

Cerebrolysin ships direct from source, discreetly worldwide with cold-chain handling where required. Delivery is approximately 6–14 business days worldwide. Shipping is free on orders over $300. Card and cryptocurrency payments are accepted.

In the United States, Cerebrolysin is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.

Cerebrolysin is a standardized porcine brain-derived peptide complex containing low-MW neuropeptides (<10 kDa) that mimic endogenous neurotrophic factors. New-U supplies Cerebrolysin as research-grade reference material for laboratory and in-vitro or animal-model investigation only. Mechanism, pharmacokinetics and study context are summarised on the Cerebrolysin research profile. Not for human use.

Reconstitution volumes and dosing reported in the literature for Cerebrolysin are described in research-model terms only. New-U Research Compounds supplies Cerebrolysin strictly for laboratory research and does not provide human-use dosing guidance. Reconstitution math and study-reported ranges are covered on the full research profile.

Lyophilised Cerebrolysin is reconstituted with bacteriostatic water — sterile water with 0.9% benzyl alcohol, the standard multi-use diluent for research peptides. New-U supplies USP-grade bacteriostatic water at https://new-u.io/peptide/bacteriostatic-water, and a free reconstitution calculator at https://new-u.io/tracker/calculator works out the volume for any peptide. Supplied for laboratory research only — not for human use.

Yes. Cerebrolysin can be ordered online directly from New-U Research Compounds with card or cryptocurrency, shipped direct from source discreetly worldwide. Delivery is approximately 6–14 business days worldwide. Free shipping applies to orders over $300.

Cerebrolysin ships in 10-vial research packs as standard, in 2 pack sizes — the larger mg vials lower the per-mg cost. Multi-pack orders get direct-from-source pricing and free shipping over $300. For wholesale or recurring laboratory-supply volumes, contact New-U Research Compounds at https://new-u.io/contact.

For research-grade Cerebrolysin, verify four things: (1) independent third-party purity testing with a batch-linked Certificate of Analysis — New-U uses Janoshik Analytics and Freedom Diagnostics at >99% HPLC; (2) lyophilised material with documented storage and handling; (3) transparent direct-from-source pricing rather than marketplace markup; and (4) clear research-use-only framing. New-U Research Compounds meets all four at https://new-u.io/peptide/cerebrolysin.

Cerebrolysin (FPF-1070) is a standardised low-molecular-weight fraction of polypeptides produced by enzymatic hydrolysis of purified porcine brain proteins - roughly 85% free amino acids plus a smaller bioactive peptide fraction, standardised to 215.2 mg/mL. The peptide fraction is what carries neurotrophic activity mimicking endogenous factors like BDNF, NGF and GDNF. It is supplied for laboratory research only.

It is a standardised mixture - a defined enzymatic hydrolysate of porcine brain tissue dominated by free amino acids with a low-molecular-weight (<10 kDa) bioactive peptide fraction. The ratios are manufactured to pharmaceutical specifications, so batch-to-batch variability is controlled, even though the product is not a single molecule.

Cerebrolysin is not FDA-approved in the United States and is sold here strictly as a research compound, not for human use. It is approved and marketed as a medicine in a number of other countries (for example Austria, Germany, China, Russia and South Korea) for indications including stroke, traumatic brain injury and dementia. Legal status varies by jurisdiction.

The evidence is genuinely mixed, which is worth stating plainly. A 2018 meta-analysis of nine RCTs (N=1,879) reported early reduction of neurological deficit versus placebo, while the more conservative 2023 Cochrane review found moderate-certainty evidence of probably little-to-no difference in all-cause death in acute ischaemic stroke. Alzheimer's trials report cognitive improvements, including combination studies with donepezil. These are research findings, not a treatment claim.

Small recombinant growth factors like BDNF are difficult to deliver to the brain because of their size and blood-brain-barrier exclusion, and they have very short half-lives in circulation. Cerebrolysin's peptide fraction is small enough to act centrally and collectively mimics the activity of several neurotrophic factors, which is why it is used as a tool compound for neurotrophic-signalling research.

It is a ready-to-use aqueous concentrate (215.2 mg/mL) given by IV infusion for larger volumes or IM injection for smaller ones; published stroke protocols describe pulse schedules such as 30 mL daily for around 10 days. Reported side effects are generally mild (transient dizziness, agitation), with clinical contraindications noted in status epilepticus and severe renal impairment. We describe these descriptively from the literature and make no dosing recommendation.

Cerebrolysin is supplied as an aqueous solution rather than a lyophilised powder. Store at 2-8 °C in a refrigerator - do not freeze, as freezing can cause precipitation of the peptide fraction. Protect from light. Once opened, use within the product's specified stability window.